Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Microbiology|November 17, 2022
A novel T4- and λ-based receptor binding protein family for bacteriophage therapy host range engineeringSamuel J Magaziner, George P C SalmondJournal of Bacteriology|February 21, 2019
The Prophages of <i>Citrobacter rodentium</i> Represent a Conserved Family of Horizontally Acquired Mobile Genetic Elements Associated with Enteric Evolution towards PathogenicitySamuel J Magaziner, Ziyue Zeng, Bihe Chen, et al.Leukemia|October 9, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutationsMaki Sakuma, Amy K Wang, Samuel J Magaziner, et al.Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2023
Novel Somatic UBA1 Variant in a Patient With VEXAS SyndromeBlanka Stiburkova, Katerina Pavelcova, Monika Belickova, et al.Open Forum Infectious Diseases|May 24, 2022
Pathogen Species Is Associated With Mortality in Nosocomial Bloodstream Infection in Patients With COVID-19Juan Gago, Thomas D Filardo, Sarah Conderino, et al.Mbio|December 5, 2019
Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus ClearanceCarol L Vinton, Samuel J Magaziner, Kimberly A Dowd, et al.Blood|March 2, 2026
Inflammatory cell death and monocyte dysfunction in VEXAS syndromePaul Breillat, Samuel J Magaziner, Stéphane M Camus, et al.The EMBO Journal|February 15, 2024
Shared and distinct mechanisms of UBA1 inactivation across different diseasesJason C Collins, Samuel J Magaziner, Maya English, et al.Biorxiv : the Preprint Server for Biology|October 24, 2023
Shared and Distinct Mechanisms of UBA1 Inactivation Across Different DiseasesJason C Collins, Samuel J Magaziner, Maya English, et al.JAMA|January 24, 2023
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationDavid B Beck, Dale L Bodian, Vandan Shah, et al.Pageof 2